Mathias Uhlén

Mathias Uhlén (born May 1954) is a Swedish scientist and Professor of Microbiology at Royal Institute of Technology (KTH), Stockholm. After a post-doc period at the EMBL in Heidelberg, Germany, he became professor in microbiology at KTH in 1988. His research is focused on protein science, antibody engineering and precision medicine and range from basic research in human and microbial biology to more applied research, including clinical applications. He is member of several academies and societies, including Royal Swedish Academy of Science (KVA), National Academy of Engineering (NAE) and the Swedish Academy of Engineering Science (IVA). Dr Uhlen was the Founding Director of the national infrastructure Science for Life Laboratory (SciLifeLab) from 2010 to 2015. Provided by Wikipedia
Showing 1 - 20 results of 72 for search 'Mathias Uhlen', query time: 0.15s Refine Results
  1. 1
    Introducing the Affinity Binder Knockdown Initiative—A public–private partnership for validation of affinity reagents
    by Tove Alm, Emma Lundberg, Mathias Uhlén
    Published 2016-03-01
    Get full text
    Article
  2. 2
    Human protein secretory pathway genes are expressed in a tissue-specific pattern to match processing demands of the secretome
    Get full text
    Article
  3. 3
    Automated solid-phase subcloning based on beads brought into proximity by magnetic force.
    Get full text
    Article
  4. 4
    A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome
    Get full text
    Article
  5. 5
    Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
    Get full text
    Article
  6. 6
    Parallel immunizations of rabbits using the same antigen yield antibodies with similar, but not identical, epitopes.
    Get full text
    Article
  7. 7
    Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
    Get full text
    Article
  8. 8
    The protein expression profile of ACE2 in human tissues
    Get full text
    Article
  9. 9
    Next generation plasma proteome profiling to monitor health and disease
    Get full text
    Article
  10. 10
    Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.
    Get full text
    Article
  11. 11
    Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
    Get full text
    Article
  12. 12
    Automated analysis and reannotation of subcellular locations in confocal images from the Human Protein Atlas.
    Get full text
    Article
  13. 13
    New Challenges to Study Heterogeneity in Cancer Redox Metabolism
    Get full text
    Article
  14. 14
    Revealing the Metabolic Alterations during Biofilm Development of <em>Burkholderia cenocepacia </em>Based on Genome-Scale Metabolic Modeling
    Get full text
    Article
  15. 15
    The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling.
    Get full text
    Article
  16. 16
    The Potential Use of Metabolic Cofactors in Treatment of NAFLD
    Get full text
    Article
  17. 17
    Dissecting antibodies with regards to linear and conformational epitopes.
    Get full text
    Article
  18. 18
    Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
    Get full text
    Article
  19. 19
    A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes
    Get full text
    Article
  20. 20
    Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search